Inactive Instrument

Qiagen NV Stock price Xetra

Equities

NL0000240000

Biotechnology & Medical Research

End-of-day quote Xetra
- EUR 0.00% Intraday chart for Qiagen NV
Sales 2024 * 2.01B 1.87B Sales 2025 * 2.16B 2B Capitalization 9.52B 8.82B
Net income 2024 * 397M 368M Net income 2025 * 446M 413M EV / Sales 2024 * 4.88 x
Net Debt 2024 * 303M 280M Net cash position 2025 * 281M 260M EV / Sales 2025 * 4.29 x
P/E ratio 2024 *
24.2 x
P/E ratio 2025 *
21.3 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.45%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 60 15-01-31
Founder 69 96-04-28
Director of Finance/CFO 56 98-12-31
Members of the board TitleAgeSince
Director/Board Member 75 11-05-31
Founder 69 96-04-28
Chairman 66 13-06-25
More insiders
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
More about the company
  1. Stock
  2. Equities
  3. Stock Qiagen N.V.
  4. Stock Qiagen NV - Xetra